Compare HALO & MUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | MUSA |
|---|---|---|
| Founded | 1998 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 7.6B |
| IPO Year | 2001 | 2013 |
| Metric | HALO | MUSA |
|---|---|---|
| Price | $67.28 | $437.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $78.18 | ★ $445.00 |
| AVG Volume (30 Days) | ★ 1.8M | 374.6K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.60% |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.56 | ★ 24.10 |
| Revenue | $151,862,000.00 | ★ $21,529,400,000.00 |
| Revenue This Year | $28.24 | $17.24 |
| Revenue Next Year | $12.79 | $3.49 |
| P/E Ratio | $26.21 | ★ $17.54 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $47.50 | $345.23 |
| 52 Week High | $82.22 | $523.09 |
| Indicator | HALO | MUSA |
|---|---|---|
| Relative Strength Index (RSI) | 35.07 | 65.25 |
| Support Level | $62.97 | $386.86 |
| Resistance Level | $68.00 | $455.58 |
| Average True Range (ATR) | 2.37 | 17.57 |
| MACD | -0.79 | 5.70 |
| Stochastic Oscillator | 6.69 | 92.53 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Murphy USA operates more than 1,700 fueling stations and convenience stores primarily across the Midwest and Southeastern United States. The firm owns about 75% of its locations, with most stores situated in high-traffic areas near Walmart supercenters. Murphy's stores typically range from 1,400-2,800 square feet, with most of its in-store sales derived from tobacco and nicotine products. The company acquired about 150 QuickChek stores in 2021, boosting its presence in grocery and foodservice. Murphy generates about two thirds of its profit from fuel retailing, with the remaining third coming from in-store sales.